• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
GAO Xiaofang,WU Hongxi,ZHU Qingyi,YANG Yong.Research advances of the tumor microenvironment and its influences on development of prostate cancer chemoresistance[J].Journal Of Pharmaceutical Research,2016,35(2):104-107[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 9379times   Download 4810次 QR Code for this article
Scan with your phone!
肿瘤微环境与前列腺癌化疗耐药的研究进展
高晓芳1,吴红茜1,朱清毅2,杨勇1
Font:Larger+|Default|Smaller-
(1.中国药科大学药物科学研究院,江苏 南京 211198;2.江苏省中医院泌尿外科,江苏 南京 210029)
摘要:
前列腺癌经雄激素剥夺疗法后,肿瘤几乎不可避免的发生激素非依赖进展和远端转移,现临床针对这种情况主要采用全身化疗,但是前列腺癌逐渐会对多种化疗药物产生抵抗。肿瘤微环境在肿瘤的发生发展中发挥重要作用,尤其与耐药性形成有着密切联系。本文对肿瘤微环境与前列腺癌耐药研究进展进行了详细的综述,为前列腺癌的治疗提供新思路和新靶标。
关键词:  肿瘤微环境  前列腺癌  化疗  耐药
DOI:10.13506/j.cnki.jpr.2016.02.014
基金项目:国家自然科学基金(No.81273547)
Research advances of the tumor microenvironment and its influences on development of prostate cancer chemoresistance
GAO Xiaofang1,WU Hongxi1,ZHU Qingyi2,YANG Yong1
(1.Drug Research Institute,China Pharmaceutical University,Nanjing 211198,China;2.Department of Urology,Jiangsu Province Hospital of TCM,Nanjing 210029,China)
Abstract:
Prostate cancer inevitably progresses to incurable castration-resistant prostate cancer and distant metastasis after androgen deprivation therapy.Chemotherapy is mainly used in clinical,but prostate will gradually more chemotherapeutic drug resistance.The tumor microenvironment plays an indispensable role in cancer progression,and it is closely linked to cancer resistance.The paper reviewed the tumor microenvironment and mechanisms of drug resistance in prostate cancer in order to provide an alternative strategy and new targets for prostate cancer therapy.
Key words:  Tumor microenvironment  Prostate cancer  Chemotherapy  Drug resistance
Today's Visits:438    Total Visits:2383115
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.